Project Grant K08AR085193
Award Date
4/1/25
Completion Date
3/31/30
Dollars Obligated
$176K
Federal Grant Program
93.846
Assistance Type
Project Grant
Place of Performance
San Francisco, CA 94143, USA
Similar Awards
This Project Grant award in the amount of $147,400 was provided by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The funding will support research by Yale University to investigate how antigen-independent activation of CD4+ T cells regulates skin fibrosis in scleroderma and sclerodermatous graft-versus-host disease. The research aims to characterize the role of...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), will provide $401,433 from September 2023 to August 2025 to support research at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. The research aims to investigate the role of protein O-GlcNAcylation in regulating keratinocyte function and its impact on skin...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $613,036 Project Grant (CFDA 93.846 - Arthritis, Musculoskeletal and Skin Diseases Research) to Fibrobiologics LLC to develop a novel therapeutic agent, M10, for treating skin fibrosis associated with systemic sclerosis (scleroderma). The award supports research activities to determine the antifibrotic activity of M10 in primary skin fibroblasts from scleroderma patients and evaluate its efficacy in...
This $1,672,816 Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) will support research at the University of Michigan to investigate how keratinocyte-derived signals regulate inflammation and innate immune responses in skin. The 5-year project aims to: 1) compare the spatiotemporal patterns of immune cell infiltration and protein kinase C activity in...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), provides $257,310.00 to the University of Illinois to investigate the role of extracellular vesicles in mediating communication between endothelial cells and fibroblasts during skin wound healing. The research aims to determine how fibroblast phenotypes are altered by endothelial cell...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) will provide $1,345,179 to The Regents of the University of California, San Francisco (UCSF) to explore modulation of lamin A/C protein lifetime as a novel axis of regulation in health and disease. The research aims to determine how lamin A/C protein stability and folded state are modulated across different tissue contexts, and how these factors impact the proteins' critical role in...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $550,909 Project Grant under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) to the University of Pittsburgh. This 5-year award, effective July 20, 2024 through June 30, 2029, supports research to understand the intrinsic and extrinsic factors regulating the development and persistence of skin-resident memory CD8 T cells. The research aims to elucidate how T cell...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), will support research to identify genetic abnormalities in skin T cells that contribute to atopic dermatitis in Asian and Hispanic populations. The total award amount is $343,904, with a project period from Sep 20, 2024 to Aug 31, 2025. The award recipient is The Regents of the University of...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA #93.846), provides $112,798 to The Leland Stanford Junior University for a 5-year project. The grant aims to characterize the essential glucose-binding proteins in the epidermis that regulate skin homeostasis. Specifically, the research will define the mechanisms by which glucose regulates the RNA-binding...
This $551,685 Project Grant awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) supports research to determine the molecular mechanisms by which cell adhesion structures called desmosomes regulate the localization and translation of mRNAs in epithelial cells. The research aims to define how desmosomes act as sensors of tissue integrity and modulate translation in...